New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a
about
Anti-infectivity of camel polyclonal antibodies against hepatitis C virus in Huh7.5 hepatomaHepatitis C virus prevalence and genotype distribution in Pakistan: Comprehensive review of recent dataRoles of lipoprotein receptors in the entry of hepatitis C virusInjecting drug use: A vector for the introduction of new hepatitis C virus genotypesAlgorithmic approach to high-throughput molecular screening for alpha interferon-resistant genotypes in hepatitis C patientsImpact of hepatitis B and hepatitis C virus infections in a hematology-oncology unit at a children's hospital in Nicaragua, 1997 to 1999.Quantitative detection of hepatitis C virus (HCV) RNA in saliva and gingival crevicular fluid of HCV-infected patients.A Natural Intergenotypic Recombinant of Hepatitis C Virus Identified in St. PetersburgDiverse Effects of Cyclosporine on Hepatitis C Virus Strain ReplicationHepatitis C Virus Subtyping by a Core-Envelope 1-Based Reverse Transcriptase PCR Assay with Sequencing and Its Use in Determining Subtype Distribution among Danish PatientsMultiplex Real-Time Reverse Transcription-PCR Assay for Determination of Hepatitis C Virus GenotypesHepatitis C virus prevalence and genetic diversity among pregnant women in Gabon, central AfricaHCV antibody response and genotype distribution in different areas and races of ChinaHepatitis C virus infection among drug injectors in St Petersburg, Russia: social and molecular epidemiology of an endemic infectionMicroRNAs as predictor markers for response to interferon treatment of chronic hepatitis C genotype-4 in Egyptian patientsStudy of PKRBD in HCV genotype 3a infected patients in response to interferon therapy in Pakistani population.Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients.Schistosomiasis does not affect the outcome of HCV infection in genotype 4-infected patientsPrevalence of Hepatitis C virus Genotype 3a in patients with Hodgkin and Non-Hodgkin Lymphoma.In vitro inhibition of hepatitis C virus by antisense oligonucleotides in PBMC compared to hepatoma cells.Hepatitis C virus infection may lead to slower emergence of P. falciparum in bloodCross reactive cellular immune response to HCV genotype 1 and 4 antigens among genotype 4 exposed subjects.Decreases in the serum VLDL-TG/non-VLDL-TG ratio from early stages of chronic hepatitis C: alterations in TG-rich lipoprotein levels.Screening the anti infectivity potentials of native N- and C-lobes derived from the camel lactoferrin against hepatitis C virus.HepG2 cells support viral replication and gene expression of hepatitis C virus genotype 4 in vitro.Hepatitis C virus core mutations reduce the sensitivity of a fluorescence enzyme immunoassayMolecular characteristic-based epidemiology of hepatitis B, C, and E viruses and GB virus C/hepatitis G virus in MyanmarEpidemiology of hepatitis C virus (HCV) infection.Predictors of response to 24-week telaprevir-based triple therapy for treatment-naïve genotype 1b chronic hepatitis C patients.The effect of pegylated interferon-alpha2b and ribavirin combination therapy for chronic hepatitis C infection in elderly patients.Haplotype analysis of interleukin-10 gene promoter polymorphisms in chronic hepatitis C infection: a case control studyPrevalence of active hepatitis c virus infection in district Mansehra PakistanHepatitis C virus genotypes circulating in district Swat of Khyber Pakhtoonkhaw, Pakistan.New combination test for hepatitis C virus genotype and viral load determination using Amplicor GT HCV MONITOR test v2.0.HIV-infected men who have sex with men who identify themselves as belonging to subcultures are at increased risk for hepatitis C infectionThe genetic diversity and evolutionary history of hepatitis C virus in VietnamAssociation of IL28B gene variations with mathematical modeling of viral kinetics in chronic hepatitis C patients with IFN plus ribavirin therapy.Pretransplant serum hepatitis C virus RNA levels predict response to antiviral treatment after living donor liver transplantationPretreatment prediction of the outcome of response-guided peginterferon-α and ribavirin therapy for chronic hepatitis C.Molecular epidemiology of hcv among health care workers of khyber pakhtunkhwa.
P2860
Q21245093-FA07B9C9-31D4-4D21-9F84-39A61EF44036Q26773191-99611F99-1C4A-413D-9FCE-D1F3250C9C68Q26777338-D7A77267-026B-46EB-87B4-7B6802166409Q26781991-7165E42A-5DD0-4527-80EA-3E2238C3D1DAQ27469401-A28E1720-231E-4897-9FEE-4526C399A7ECQ27471038-A92DC996-B3F6-4CD5-BDF4-D7EF68D23FE6Q27472050-D55E2B8E-811C-4EED-90F8-0F6B5969E2B3Q27472858-1229F43A-8101-4BF2-9D7B-573E78C70D36Q27473218-5D160C77-2A3B-4500-B9DC-6F5CA3A6F3B9Q27473362-5406C309-862D-4B58-81EA-0299348F2D3DQ27477767-A24C8D55-CDC1-446D-B26A-156C29C595CDQ27486393-A31DC19C-07C0-49CE-94CE-A7694F4D1D55Q27488854-CD9F7934-1666-424D-B8EE-8FB53F9804A3Q27490176-E875FA9E-6989-4B6A-9DE4-AAB9E6683621Q28545051-05705079-AE86-490D-91D6-7B1B511BFAD5Q30356602-68732BE0-C47D-4569-9C15-7C3BD105B938Q30422199-43F0F9C9-4FEF-4432-840C-A8230D159554Q33588479-1257C32C-B878-4B3E-B020-73F0EC8B0798Q33645331-EEF0576C-AF63-407B-AE91-25B9A506B362Q33759357-763C2DCE-1A59-442B-94AF-4C56A02B7E95Q33798041-3D3DFD5F-DF15-4056-9C26-341DC38F0A0DQ33826033-32393EA6-DE21-431E-96A6-EE708CC1A3B4Q33833805-EB249D25-DA1B-4EF9-836C-60D21528B766Q33863096-7EB75F8F-6FF7-43AD-BD58-4A8045E87319Q33867009-8D5B280D-8ECA-48E0-899C-0BFEA3141F27Q33969741-F7CFC333-1B0A-47AD-87E7-6CD9F436CE14Q33971990-EF0D17B1-E936-46D7-906A-2B163BEBECC5Q33995067-4F83F1A2-ED2F-4FEE-98E9-F34EE5E480D7Q34114361-ED98A977-BC82-4070-8827-8D9239A75B49Q34190390-0E65C09E-6F37-4A40-B572-0DF83E195870Q34283995-ACF45323-1586-4AA6-85D3-FC82379CE81CQ34375473-AC9D8DF2-2BF8-4D86-9BCF-9C9FDE3D6AFDQ34522014-7FAEA597-A212-4221-8AB9-EED5E7179F35Q34605687-C184CCC4-FEA3-408A-8AD5-BBE081F29EFFQ34613207-8746C73F-AEF6-417F-8B85-504F788E87EAQ34615527-C5C975C3-3AC2-49F4-98AC-1FFB8357D931Q34621423-69595052-8917-4057-B655-2A1E2575CBF2Q34625761-178BBCB8-0839-4761-923D-622179A95411Q34679526-FE66AD09-C826-44E1-8C1A-E3C00B6F6E6EQ34698904-5F57EABF-F383-4975-9F7F-B40592AE373B
P2860
New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a
description
1997 nî lūn-bûn
@nan
1997 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
New hepatitis C virus (HCV) ge ...... 2a, 2b, 3a, 3b, 4, 5a, and 6a
@ast
New hepatitis C virus (HCV) ge ...... 2a, 2b, 3a, 3b, 4, 5a, and 6a
@en
New hepatitis C virus (HCV) ge ...... 2a, 2b, 3a, 3b, 4, 5a, and 6a
@nl
type
label
New hepatitis C virus (HCV) ge ...... 2a, 2b, 3a, 3b, 4, 5a, and 6a
@ast
New hepatitis C virus (HCV) ge ...... 2a, 2b, 3a, 3b, 4, 5a, and 6a
@en
New hepatitis C virus (HCV) ge ...... 2a, 2b, 3a, 3b, 4, 5a, and 6a
@nl
prefLabel
New hepatitis C virus (HCV) ge ...... 2a, 2b, 3a, 3b, 4, 5a, and 6a
@ast
New hepatitis C virus (HCV) ge ...... 2a, 2b, 3a, 3b, 4, 5a, and 6a
@en
New hepatitis C virus (HCV) ge ...... 2a, 2b, 3a, 3b, 4, 5a, and 6a
@nl
P2093
P2860
P3181
P1476
New hepatitis C virus (HCV) ge ...... 2a, 2b, 3a, 3b, 4, 5a, and 6a
@en
P2093
M Mizokami
R Williams
P2860
P3181
P407
P577
1997-01-01T00:00:00Z